Advertisement

Advertisement

HK:2142 Stock Latest News

HBM Holdings Grants Performance-Linked Share Awards to Employee

Company AnnouncementsHBM Holdings Grants Performance-Linked Share Awards to Employee

HBM Holdings’ 2025 Profit Surges as Global Pharma Alliances Deepen

PremiumCompany Announcements

HBM Holdings’ 2025 Profit Surges as Global Pharma Alliances Deepen

7d ago

HBM Holdings Sets Board Meeting to Approve 2025 Annual Results

PremiumCompany Announcements

HBM Holdings Sets Board Meeting to Approve 2025 Annual Results

19d ago

HBM Wins China IND Nod for Long-Acting Atopic Dermatitis Antibody

PremiumCompany Announcements

HBM Wins China IND Nod for Long-Acting Atopic Dermatitis Antibody

28d ago

HBM Holdings Strikes Global Licensing and Equity Deal for HBM4003 with Solstice Oncology

PremiumCompany Announcements

HBM Holdings Strikes Global Licensing and Equity Deal for HBM4003 with Solstice Oncology

1M ago

HBM Holdings Corrects Share Option Data Across Past Disclosures

PremiumCompany AnnouncementsHBM Holdings Corrects Share Option Data Across Past Disclosures

2M ago

HBM Holdings Forecasts Sharp Profit Surge on Recurring Biotech Collaboration Revenue

Company Announcements

HBM Holdings Forecasts Sharp Profit Surge on Recurring Biotech Collaboration Revenue

2M ago

HBM Holdings Launches Up to HK$300 Million On‑Market Share Buyback

Company Announcements

HBM Holdings Launches Up to HK$300 Million On‑Market Share Buyback

2M ago

HBM Holdings Deepens Ties With Spruce Biosciences via Warrant Exercise

PremiumCompany Announcements

HBM Holdings Deepens Ties With Spruce Biosciences via Warrant Exercise

3M ago

HBM Holdings Grants 309,000 Share Options to Non-Connected Employee

PremiumCompany Announcements

HBM Holdings Grants 309,000 Share Options to Non-Connected Employee

3M ago

HBM Holdings Partners with Bristol Myers Squibb for Antibody Development

PremiumCompany Announcements

HBM Holdings Partners with Bristol Myers Squibb for Antibody Development

4M ago

HBM Holdings Enhances Collaboration with AstraZeneca for Biotherapeutic Development

PremiumCompany Announcements

HBM Holdings Enhances Collaboration with AstraZeneca for Biotherapeutic Development

4M ago

HBM Holdings Partners with Pfizer for Antibody Discovery

PremiumCompany AnnouncementsHBM Holdings Partners with Pfizer for Antibody Discovery

5M ago

HBM Holdings Partners with Umoja Biopharma for CAR-T Cell Development

Company Announcements

HBM Holdings Partners with Umoja Biopharma for CAR-T Cell Development

5M ago

HBM Holdings Ltd. Announces Share Options and Awards Grant

Company Announcements

HBM Holdings Ltd. Announces Share Options and Awards Grant

7M ago

HBM Holdings Completes Successful Share Placement to Boost R&D and Innovation

PremiumCompany Announcements

HBM Holdings Completes Successful Share Placement to Boost R&D and Innovation

7M ago

HBM Holdings Ltd. Grants Share Options and Awards to Employees

PremiumCompany Announcements

HBM Holdings Ltd. Grants Share Options and Awards to Employees

7M ago

HBM Holdings Announces Share Placement to Raise HK$511.7 Million

PremiumCompany Announcements

HBM Holdings Announces Share Placement to Raise HK$511.7 Million

7M ago

HBM Holdings Reports Strong Revenue and Profit Growth in H1 2025

PremiumCompany Announcements

HBM Holdings Reports Strong Revenue and Profit Growth in H1 2025

7M ago

HBM Holdings to Review Interim Results in Upcoming Board Meeting

PremiumCompany AnnouncementsHBM Holdings to Review Interim Results in Upcoming Board Meeting

8M ago

HBM Holdings to Present Promising Cancer Therapy Data at ESMO 2025

Company Announcements

HBM Holdings to Present Promising Cancer Therapy Data at ESMO 2025

8M ago

HBM Holdings Projects Significant Profit Growth for First Half of 2025

Company Announcements

HBM Holdings Projects Significant Profit Growth for First Half of 2025

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >